Table 3.
Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

* Stage 2 of the phase II trial will only evaluate PRM-151 as monotherapy.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal